Search results
Gilead Sciences Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 5 hours agoGilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-06-27, with the ex-dividend date set for 2024-06-14....
How Bad Is It to Borrow My Partner’s Toothbrush From Time to Time?
Self via Yahoo News· 2 days agoMore specifically, borrowing any personal hygiene tool (like a razor or toothbrush) can potentially...
GSK signs AI pact with Ochre to pinpoint source of liver diseases
FierceBiotech· 2 days agoGSK and Ochre Bio will work together in a $37.5 million partnership to pinpoint the drivers of liver disease. The new partnership, announced Wednesday morning, will see GSK ...
Panel discussion addresses history of harm reduction in Asheville
Mountain Xpress· 9 hours agoHarm reduction, an evidence-based set of practices that reduces harm among people who use drugs, is ...
Axios Detroit
Axios· 3 days agoDetroit City Council member Scott Benson is advocating for a new version of his previously rejected food safety proposal that's been in the works for six years and would affect ...
Let’s Talk: Sexually Transmitted Infections
Tahoe Daily Tribune· 5 days agoSexually transmitted infections (STIs) are on the rise in the United States. STIs are infections passed from person to person through sexual contact....
What vaccine protects against cancer and is recommended for everyone?
Galveston County Daily News· 2 days agoIn honor of all the students taking finals this time of the year, here is a little Vaccine Smarts...
CDC director praises the ‘great work’ done by Southern Nevada Health District
Las Vegas Sun· 1 day agoC., to encourage parents of young children to get a COVID-19 vaccine. Dr. Mandy Cohen, director of...
Bayesian Capital Management LP Invests $4.79 Million in Hologic, Inc. (NASDAQ:HOLX)
ETF DAILY NEWS· 1 day agoBayesian Capital Management LP purchased a new position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) in the 4th quarter, according to the company in its most recent ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 6 days agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat ...
